A

Allakos (ALLK)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Allakos (ALLK)

Allakos Inc. is a clinical stage biopharmaceutical company developing therapeutic antibodies that selectively target immunomodulatory receptors present on the surface of immune effector cells involved in allergic, inflammatory and proliferative disea... Read more

  • USD4.56
  • USD4.56
  • USD4.14
  • USD8.73
  • -25.40%
  • --
  • 975.65k
  • 1.34M
  • 395M
  • 2.54
  • -22.00%

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.